SCHEMBL1797284

SCHEMBL1797284

O=C(COCC(=O)Nc1ccc(-c2ccncc2)cc1C(=O)O)Nc1ccccc1Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.48
ROCK2 O75116 1/20 0.48
MAP4K4 O95819 1/20 0.48
GSK3B P49841 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
MKNK2 Q9HBH9 1/20 0.48
KDM4E B2RXH2 2/20 0.46
POLB P06746 1/20 0.46
PTPN1 P18031 2/20 0.44
AAK1 Q2M2I8 2/20 0.43
LRRK2 Q5S007 1/20 0.43
SERPINE1 P05121 1/20 0.43
KDM4C Q9H3R0 2/20 0.43
ALDH1A1 P00352 2/20 0.43
PKM P14618 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
MAPT P10636 1/20 0.42
RECQL P46063 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1799011 0.91 CDC7 (0.46) CDC7ROCK2MAP4K4GSK3BCLK4
SCHEMBL1799401 0.82 PTPN1 (0.64) KDM4EPOLBPTPN1SERPINE1ALDH1A1
SCHEMBL1797277 0.81 AAK1 (0.46) CDC7ROCK2MAP4K4GSK3BCLK4
SCHEMBL1015633 0.77 SERPINE1 (0.56) KDM4EPOLBSERPINE1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL1016123 0.76 SERPINE1 (0.55) KDM4EPOLBSERPINE1ALDH1A1MAPT
SCHEMBL1800597 0.75 PTPN1 (0.56) KDM4EPOLBPTPN1SERPINE1ALDH1A1
SCHEMBL1015619 0.75 SERPINE1 (0.49) KDM4EPOLBSERPINE1ALDH1A1MAPT
SCHEMBL1798523 0.75 SERPINE1 (0.73) AAK1SERPINE1ALDH1A1
SCHEMBL1014958 0.74 SERPINE1 (0.55) KDM4EPOLBSERPINE1ALDH1A1L3MBTL1
SCHEMBL1795910 0.74 SERPINE1 (0.72) AAK1SERPINE1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US claimed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US claimed
US-10092537-B2 Use for PAI-1 inhibitor RENASCIENCE CO., LTD. (JP) 2018-10-09 US disclosed
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2016-06-09 US disclosed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 EP disclosed
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 CDC7 1447/4885ROCK2 4012/4885MAP4K4 3113/4885
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 CDC7 4071/4885ROCK2 2570/4885MAP4K4 1926/4885
US-10092537-B2 Use for PAI-1 inhibitor SERPINE1, SERPINC1, SERPINB1 CDC7 1362/4885ROCK2 4164/4885MAP4K4 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.